TERT-BUTYL (3R,5S)-3,5-DIHYDROXY-6-((5-METHYL-1,3,4-THIADIAZOL-2-YL)SULFONYL)HEXANOATE
UNII 2RVC3GZZ9Q
Substance Identification & Data
This profile provides standardized clinical and technical data for Tert-butyl (3r,5s)-3,5-dihydroxy-6-((5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl)hexanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2RVC3GZZ9Q.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C13H22N2O6S2 QTJGHELELVIPGK-ZJUUUORDSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Tert-butyl (3r,5s)-3,5-dihydroxy-6-((5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl)hexanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.